BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aspira Pathlab & Diagnostics Ltd Industry :  Healthcare
BSE Code
540788
ISIN Demat
INE500C01017
Book Value (Rs)
11.8847761
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
98
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.04 crore in the June 2026 quarter
12-Aug-26   Hrs IST

Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.04 crore in the quarter ended June 2026 as against net profit of Rs 0.47 crore during the previous quarter ended June 2025. Sales rose 17.52% to Rs 6.17 crore in the quarter ended June 2026 as against Rs 5.25 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales6.175.25 18
OPM %5.5115.62 -
PBDT0.370.84 -56
PBT-0.040.47 PL
NP-0.040.47 PL

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)